Chlamydia
Antigen Discovery, Inc. Awarded Grant for Chlamydia Vaccine Development
Published in Women's Health Weekly, October 8th, 2009
Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009. The $1.8 million grant will fund efforts to further test and validate novel candidate antigens discovered during the Company's successful STTR Phase I program. ADi intends to develop the novel antigens as core protective components in a vaccine against Chlamydia. ADi will collaborate with investigators in the Department of Pathology & Laboratory Medicine of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- American Friends of Tel Aviv University
Infertility and the battle of the sexes - Elsevier
Treating depression in pregnancy - Yale University
Researchers identify new brain pathway for regulating weight and bone mass - Angiogenesis
Data on angiogenesis detailed by K. Elzarrad and co-authors - BioSante Pharmaceuticals, Inc.
BioSante Pharmaceuticals and Cell Genesys Announce Final Exchange Ratio for Merger - Brain Metastasis
Research from University of Virginia broadens understanding of brain metastasis - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
